Allogeneic Mesenchymal Stem Cells Induce Regulatory T Cells and Suppress Aneurysm Inflammation: Interim Results of the Phase 1 ARREST Trial

The objective of this clinical trial was to assess the efficacy of allogeneic mesenchymal stem cells (MSCs) in inducing Tr1 cells and suppressing AAA inflammation.

Source: Journal of Vascular Surgery - August 21, 2019 Category: Surgery Authors: Katherin Leckie, Linden L. Green, Justin R. King, Keisin S. Wang, Raghu L. Motaganahalli, Andres Fajardo, Michael P. Murphy, John G. Maijub Tags: Abstract from the 2019 Midwestern Vascular Surgical Society Annual Meeting Source Type: research